Article
LRRK2: Molecular Mechanisms in Parkinson's Disease.
International journal of molecular sciences - 25 Aug 2026
Arias-Carrión Oscar, Guerra-Crespo Magdalena, Ortuño-Sahagún Daniel, Ortega-Robles Emmanuel
Abstract excerpt
Leucine-rich repeat kinase 2 (LRRK2) has emerged as a central molecular node linking genetic risk, membrane trafficking, lysosomal homeostasis, and immune signalling in Parkinson's disease (PD). Rather than functioning as a conventional protein kinase, LRRK2 operates as a conformationally regulated, Rab-directed signalling machine whose activity is governed by long-range interdomain communication, membrane...
Read the complete abstract on PubMedTopics
- Humans
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
- Parkinson Disease
- Animals
- rab GTP-Binding Proteins
- Signal Transduction
